
Kyto Technology and Life Science, Inc.
KBPHOTCFinancial Services
$1.00
$-0.84(-45.65%)
Market Cap$13287600
P/E Ratio—
52W High$1.0
52W Low$1.0
Kyto Technology and Life Science, Inc. (KBPH) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · KBPH · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2021-03 | 2020-03 | 2019-03 | 2018-03 | 2017-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | 0.11% | 0.10% | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | ($0.00B) | $0.00B | $0.00B |
| Net Income | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.06 | $-0.13 | $-0.04 | $-0.03 | $-0.03 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.00B | 0.00B | 0.00B |
| EBITDA | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Kyto Technology and Life Science, Inc. data
About Kyto Technology and Life Science, Inc. (KBPH) Income Statement
Kyto Technology and Life Science, Inc. (KBPH) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2021, KBPH reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of $0.00B — a net profit margin of —.
Frequently asked questions
KBPH · 4 questionsKyto Technology and Life Science, Inc. (KBPH) reported revenue of $0.00B for 2021, down 100.0% year-over-year.
KBPH revenueKBPH salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09